Pre-transplant low level HLA antibody shows a composite poor outcome in long-term outcome of renal transplant recipients

References

• Impedovo SV, Martino P, Palazzo S, et al. Value of the resistive index in patient and graft survival after kidney transplant. Arch Ital Urol Androl. 2012;84:279–282
   PubMedGoogle Scholar
• Brian JN, Dirk RK. Diagnosis and prevention of chronic kidney allograft loss. Lancet. 2011;378:1428–1437
   PubMedGoogle Scholar
• Fonseca I, Almeida M, Martins LS, et al. First-year renal function predicts long-term renal allograft loss. Transplant Proc. 2011;43:106–112
   PubMedGoogle Scholar
• Kittleson MM, Kobashigawa JA. Antibody-mediated rejection. Curr Opin Organ Transplant. 2012;17:551–557
   PubMedGoogle Scholar
• Loupy A, Hill GS, Jordan SC. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat Rev Nephrol. 2012;8:348–357
   PubMed Web of Science ®Google Scholar
• Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol. 2010;21:1398–1306
   PubMed Web of Science ®Google Scholar
• Aubert V, Venetz JP, Pantaleo G, et al. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol. 2009;70:580–583
   PubMedGoogle Scholar
• Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant. 2008;8:324–331
   PubMed Web of Science ®Google Scholar
• Amico P, Hönger G, Mayr M, et al. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation. 2009;87:1681–1688
   PubMed Web of Science ®Google Scholar
• Gupta A, Iveson V, Varagunam M, et al. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant? Transplantation. 2008;85:1200–1204
   PubMed Web of Science ®Google Scholar
• Vlad G, Ho EK, Vasilescu ER, et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol. 2009;70:589–594
   PubMed Web of Science ®Google Scholar
• Thammanichanond D, Athimang W, Paisooksantivatana K, et al. Renal transplantation in patients with pre-transplantation donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant. 2007;7:2371–2377
   PubMedGoogle Scholar
• Pollinger HS, Stegall MD, Gloor JM, et al. Kidney transplantation in patients with antibodies against donor HLA class II. Am J Transplant. 2007;7:857–863
   PubMedGoogle Scholar
• Georg Dieplinger, Vanessa Ditt, Wolfgang Arns, et al. Impact of de novo donor-specific HLA antibodies detected by Luminex solid-phase assay after transplantation in a group of 88 consecutive living-donor renal transplantations. Transplant Int. 2014;27:60–68
   Google Scholar
• Gibney EM, Cagle LR, Freed B, et al. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant. 2006;21:2625–2629
   PubMed Web of Science ®Google Scholar
• Terasaki PI. Antibody response to homografts II. Preliminary studies of the time of appearance of lympho agglutins upon homografting. Am Surg. 1959;25:896–899
   PubMedGoogle Scholar
• Terasaki PI. Humoral theory of transplantion. Am J Transplant. 2003;3:665–673
   PubMed Web of Science ®Google Scholar
• Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant. 2008;8:2335–2342
   PubMedGoogle Scholar
• Montgomery RA, Cozzi E, West LJ, et al. Humoral immunity and antibody-mediated rejection in solid organ transplantation. Semin Immunol. 2011;23:224–234
   PubMed Web of Science ®Google Scholar
• Cai J, Terasaki PI. Humoral theory of transplantation: Mechanism, prevention, and treatment. Hum Immunol. 2005;66:334–342
   PubMedGoogle Scholar
• Kubal C, Cockwell P, Gunson B, et al. Chronic kidney disease after nonrenal solid organ transplantation: A histological assessment and utility of chronic allograft damage index scoring. Transplantation. 2012;93:406–411
   PubMedGoogle Scholar
• Haynes R, Baigent C, Harden P, et al. Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: Background, rationale, and study protocol. Transplant Res. 2013;2:7. doi: 10.1186/2047-1440-2-7
   PubMedGoogle Scholar
• Lee PC, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation. 2002;74:1192–1194
   PubMed Web of Science ®Google Scholar
• Thernvath TP, Saidman SL, Mauiyyedi S, et al. Control of anti-donor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation. 2001;72:77–83
   PubMedGoogle Scholar
• Zhang X, Reed EF. Effect of antibodies on endothelium. Am J Transplant. 2009;9:2459–2465
   PubMed Web of Science ®Google Scholar
• Cosio FG, Lager DJ, Lorenz EC, et al. Significance and implications of capillaritis during acute rejection of kidney allografts. Transplantation. 2010;89:1088–1094
   PubMed Web of Science ®Google Scholar
• Cornell LD. Renal allograft pathology in the sensitized patient. Curr Opin Organ Transplant. 2013;18:327–336
   PubMed Web of Science ®Google Scholar
• Sutherland SM, Chen G, Sequeira FA, et al. Complement-fixing donor-specific antibodies identified by a novel C1q assay are associated with allograft loss. Pediatr Transplant. 2012;16:12–17
   PubMed Web of Science ®Google Scholar
• Toyoda M, Ge S, Suviolahti E, et al. IFNγ production by NK cells from HLA-sensitized patients after in vitro exposure to allo-antigens. Transpl Immunol. 2012;26:107–112
   PubMedGoogle Scholar
• Banasik M, Boratyńska M, Kocielska-Kasprzak K, et al. The impact of de novo donor-specific anti-human leukocyte antigen antibodies on 5-year renal transplant outcome. Transplant Proc. 2013;45:1449–1452
   PubMedGoogle Scholar
• Riethmuller S, Ferrari-Lacraz S, Müller MK, et al. Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation. 2010;90:160–167
   PubMed Web of Science ®Google Scholar
• Reinsmoen NL, Lai CH, Vo A, et al. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy. Transplantation. 2008;86:820–825
   PubMed Web of Science ®Google Scholar
• Gloor JM, Winters JL, Cornell LD, et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant. 2010;10:582–589
   PubMed Web of Science ®Google Scholar